SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending amid surging excitement driven by positive clinical updates, including durable complete remissions in lymphoma with its CAR-NK cell therapy and promising enrollment in a bladder cancer trial. The community is vigorously discussing the stock's significant short interest and anticipating a potential squeeze, fueled by calls for broader regulatory recognition of its innovative, chemo-free cancer treatments. Many investors believe these developments, coupled with founder Dr. Patrick Soon-Shiong's proven track record, position IBRX for substantial long-term impact in oncology.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept Inc. ($VERO) is trending significantly following the announcement that Madryn Asset Management acquired a 91% stake in the company. This substantial ownership has ignited community speculation about a highly compressed float, leading to intense discussion around short squeeze potential and comparisons to historic market events. Traders are actively driving momentum, eyeing considerable gains amidst the drastically reduced publicly available shares.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending due to significant upward revisions to its 2026 revenue guidance, strong preliminary 2025 results, and a surging backlog, bolstered by a substantial cash infusion from recent financing. The market is keenly watching its imminent Investor Day, with community sentiment split between strong bullish conviction for its autonomous systems and drone technology and concerns over short-term "sell the news" dynamics and option expiry manipulation. This comes as the company continues to position itself in the growing defense and security sector, notably with a strategic government tender for border protection.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is currently trending amid heightened investor discussion concerning recent college sports betting scandals and their potential impact on the industry's integrity, alongside ongoing competition from prediction markets. Despite recent analyst upgrades and the company expanding its iGaming presence and increasing its share buyback program, the community expresses frustration over the stock's persistent volatility and perceived market manipulation.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to its recent prime contract position on the U.S. Missile Defense Agency's SHIELD program, part of the broader "Golden Dome" strategy. This development has fueled massive bullish sentiment among investors, who celebrate it as validation of the company's dual-use technology and anticipate a significant short squeeze. However, some skeptics caution about the stock's high valuation and the contract's nature, which offers eligibility to bid rather than guaranteed revenue.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is soaring amidst a flurry of analyst upgrades, with new price targets pushing toward $100-$110, fueling intense community buzz about hitting triple digits. Key catalysts include upcoming Electron missions, progress on significant defense contracts, and anticipation for the Neutron rocket's maiden flight, positioning RKLB as a critical player in the expanding space and national security sectors. While some debate its current valuation, many view it as a compelling long-term growth story benefiting from broader industry tailwinds.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to a significant joint venture with a Saudi Arabian industrial conglomerate to build an up to $1.5 billion rare earth processing facility, which secures 100% offtake for its Greenland project and strengthens the supply chain for U.S. defense. The community is highly bullish on the long-term potential of Greenland's critical minerals for national security, though many express frustration over perceived market manipulation attempting to suppress the stock despite overwhelmingly positive news.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is trending due to its pivotal move into AI infrastructure, following a new long-term data center lease agreement with AMD at its Rockdale facility. This strategic expansion, funded by a significant Bitcoin sale and land acquisition, positions Riot as a key player beyond pure crypto mining, with the community actively debating its potential in the high-demand AI sector compared to its peers.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is a major topic as the software sector faces significant pressure from intensifying AI disruption fears and recent analyst downgrades. While many express concern over the competitive landscape from AI-powered alternatives and new offerings, a substantial segment of the community views the current market reaction as an oversold buying opportunity, emphasizing Adobe's strong fundamentals and cash-generating business model.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials ($RGNT) is trending after recent patent news for its GelrinC product, which is already approved in Europe and boasts substantial market potential. The community is intensely focused on its extremely low public float and recent IPO status, speculating on a significant price surge if volume increases and a potential short squeeze develops. Many investors are actively accumulating shares, anticipating a major breakout with considerable upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DGNMF 

https://www.reddit.com/r/pennystocks/s/U8u2DS80o6

[Warning] Banned from QIMC Discord for asking about the DMED healthcare-to-hydrogen pivot (after CEO promised transparency)

I am posting this to warn current and potential investors about the extreme censorship in the QIMC / DiagnaMed (DMED) Discord community. Despite receiving a direct DM from CEO John Karagiannidis apologizing for prior moderation issues and promising transparency, I was banned immediately for asking a fundamental due diligence question regarding the company’s pivot and dual leadership structure.

I have been researching the relationship between Quebec Innovative Materials Corp (QIMC) and DiagnaMed (DMED). Specifically, I wanted to understand the transition of DMED from a healthcare technology company (AI/Diagnostics) to a &quot;natural hydrogen&quot; play, and how the dual-CEO role (John K leading both entities) impacts strategy.

Reddit

StockTwits For Android 

Diagnamed Holdings Corp



[Warning] Banned from QIMC Discord for asking about the DMED healthcare-to-hydrogen pivot (after CEO promised transparency)

I am posting this to warn current and potential investors about the extreme censorship in the QIMC / DiagnaMed (DMED) Discord community. Despite receiving a direct DM from CEO John Karagiannidis apologizing for prior moderation issues and promising transparency, I was banned immediately for asking a fundamental due diligence question regarding the company’s pivot and dual leadership structure.

I have been researching the relationship between Quebec Innovative Materials Corp (QIMC) and DiagnaMed (DMED). Specifically, I wanted to understand the transition of DMED from a healthcare technology company (AI/Diagnostics) to a "natural hydrogen" play, and how the dual-CEO role (John K leading both entities) impacts strategy.

Applied Digital Corporation

Quebec Innovative Materials Corp

Dominic Reiss

My Question (Paraphrased): &quot;Can management outline the timeline and rationale for DiagnaMed’s transition from healthcare technology to a focus on natural hydrogen and energy IP? How and when was this pivot formalized in corporate filings, and how does the dual leadership arrangement (John K as CEO of both) support the long-term strategy?&quot;

I was banned. No warning, no answer, just an immediate ban.

 It is a major red flag for investors when:
A company pivots sectors (Healthcare -&gt; Energy) and refuses to answer questions about the timeline or rationale.

The claimed CEO in this discord privately claims to value transparency but the public forum is aggressively sanitized of any complex questions.

Investors are prevented from discussing the dual-role leadership structure.

If you are in the QIMC or DMED Discord, be aware that you are likely in a curated echo chamber where legitimate due diligence is treated as FUD.

My Question (Paraphrased): "Can management outline the timeline and rationale for DiagnaMed’s transition from healthcare technology to a focus on natural hydrogen and energy IP? How and when was this pivot formalized in corporate filings, and how does the dual leadership arrangement (John K as CEO of both) support the long-term strategy?"

I was banned. No warning, no answer, just an immediate ban.

 It is a major red flag for investors when:
A company pivots sectors (Healthcare -> Energy) and refuses to answer questions about the timeline or rationale.

The claimed CEO in this discord privately claims to value transparency but the public forum is aggressively sanitized of any complex questions.

Investors are prevented from discussing the dual-role leadership structure.

If you are in the QIMC or DMED Discord, be aware that you are likely in a curated echo chamber where legitimate due diligence is treated as FUD.

@domom I was the moderator who banned that account. It wasn’t for asking questions. It was banned for the attitude. The tone was aggressive and they were threatening mods, the discord is a discussion group run by volunteers and nobody is owed anything and if the rules of the community aren’t followed or there is any abuse of members or moderators then that user will be banned.

StockTwits for iOS

 I was the moderator who banned that account. It wasn’t for asking questions. It was banned for the attitude. The tone was aggressive and they were threatening mods, the discord is a discussion group run by volunteers and nobody is owed anything and if the rules of the community aren’t followed or there is any abuse of members or moderators then that user will be banned.

Black Tusk Resources Inc

Alex Tobler

@domom  
I am shooting from older memory here. Back when Fabio Chianelli was near FDA approval with Pharmather, researching him, I saw he was a serial entrepreneur, and was even selling or leasing some sort of storage containers. And he was CEO of DiagnaMed. Brain health. I think they even had some other odd thing, too. DiagnaMed was a company in search of a market to enter. Fabio appears to have worked with his friends to enter the hydrogen market as well. Fabio stepped down as CEO of DiagnaMed (he&#39;s still on the Board) to focus on Pharmather, and they got John to be their CEO. I saw that DiagnaMed looked to really have a serious future, and they were posting on x.com some great news, regularly. Thinking they&#39;d actually found a very promising market, were going for it, had a top guy leading the company now, and were as yet basically unknown, I bought in. I was the first follower on StockTwits. Then I bought into Quebec Innovative. That is what I can share.

X (formerly Twitter)

StockTwits Web

  
I am shooting from older memory here. Back when Fabio Chianelli was near FDA approval with Pharmather, researching him, I saw he was a serial entrepreneur, and was even selling or leasing some sort of storage containers. And he was CEO of DiagnaMed. Brain health. I think they even had some other odd thing, too. DiagnaMed was a company in search of a market to enter. Fabio appears to have worked with his friends to enter the hydrogen market as well. Fabio stepped down as CEO of DiagnaMed (he's still on the Board) to focus on Pharmather, and they got John to be their CEO. I saw that DiagnaMed looked to really have a serious future, and they were posting on 

 some great news, regularly. Thinking they'd actually found a very promising market, were going for it, had a top guy leading the company now, and were as yet basically unknown, I bought in. I was the first follower on StockTwits. Then I bought into Quebec Innovative. That is what I can share.